[{"id":"6a7e9990-a739-46e3-a955-92f98bf580c9","acronym":"","url":"https://clinicaltrials.gov/study/NCT04927416","created_at":"2021-06-16T18:52:38.190Z","updated_at":"2025-02-25T15:35:06.877Z","phase":"Phase 2","brief_title":"The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer","source_id_and_acronym":"NCT04927416","lead_sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","biomarkers":" SSTR2","pipe":" | ","alterations":" SSTR2 expression • SSTR2 overexpression","tags":["SSTR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR2 expression • SSTR2 overexpression"],"overall_status":"Recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 10/25/2021","start_date":" 10/25/2021","primary_txt":" Primary completion: 11/30/2030","primary_completion_date":" 11/30/2030","study_txt":" Completion: 11/30/2030","study_completion_date":" 11/30/2030","last_update_posted":"2025-02-10"},{"id":"466aa3f3-e407-4613-8085-e7a9cfdf7bbd","acronym":"","url":"https://clinicaltrials.gov/study/NCT01967537","created_at":"2021-02-11T16:52:52.795Z","updated_at":"2024-07-02T16:36:53.453Z","phase":"Phase 2","brief_title":"Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors","source_id_and_acronym":"NCT01967537","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" SSTR • SSTR2","pipe":" | ","alterations":" SSTR2 expression • SSTR Expression • SSTR2 overexpression","tags":["SSTR • SSTR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR2 expression • SSTR Expression • SSTR2 overexpression"],"overall_status":"Completed","enrollment":" Enrollment 341","initiation":"Initiation: 10/18/2013","start_date":" 10/18/2013","primary_txt":" Primary completion: 12/17/2017","primary_completion_date":" 12/17/2017","study_txt":" Completion: 03/12/2018","study_completion_date":" 03/12/2018","last_update_posted":"2019-11-19"}]